CCT020312 Inhibits Triple-Negative Breast Cancer Through PERK Pathway-Mediated G1 Phase Cell Cycle Arrest and ApoptosisXiaoli Li, Weiying Zhou, Xiaoping Yu et al.|Frontiers in Pharmacology|2020Cited by 34
Endoplasmic reticulum stress inhibits AR expression via the PERK/eIF2α/ATF4 pathway in luminal androgen receptor triple-negative breast cancer and prostate cancerXiaoli Li, Weiying Zhou, Xiaoping Yu et al.|npj Breast Cancer|2022Cited by 29
<p>The Anti-Breast Cancer Effect and Mechanism of Glimepiride-Metformin Adduct</p>Liangyuan Long, Weiying Zhou, Xiangnan Hu et al.|OncoTargets and Therapy|2020Cited by 13
Screening of and mechanism underlying the action of serum- and glucocorticoid-regulated kinase 3-targeted drugs against estrogen receptor-positive breast cancerDuanfang Zhou, Weiying Zhou, Xiaoping Yu et al.|European Journal of Pharmacology|2022Cited by 6
SGK3 promotes estrogen receptor‐positive breast cancer proliferation by activating STAT3/ZMIZ2 pathway to stabilise β‐cateninLie Yuan, Weiying Zhou, Yongqing Cai et al.|British Journal of Pharmacology|2025Cited by 1